3 results
Approved WMORecruiting
The overall objective is to assess the effectiveness of treating patients with corticosteroids prior to surveillance in order to diminish the pitfall of active inflammation.
Approved WMOCompleted
To investigate whether ticagrelor increases adenosine receptor stimulation in humans in vivo by ENT inhibition.
Approved WMOCompleted
The current study is being conducted to determine whether long-term dual-antiplatelet therapy with ticagrelor in combination with ASA (recommended daily dose 75-100 mg) is beneficial in patients with history of MI (1-3 years ago) and additional risk…